Detalles de la búsqueda
1.
Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study.
J Child Psychol Psychiatry
; 57(6): 717-28, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26871297
2.
The clinical impact of switching attention deficit hyperactivity disorder patients from OROS(®)-MPH to Novo-MPH ER-C(®): A paediatric practice review.
Paediatr Child Health
; 18(2): 70-3, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24421659
3.
Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate.
J Atten Disord
; 27(7): 743-756, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37144295
4.
A retrospective medical chart review of clinical outcomes in children and adolescents with attention-deficit/hyperactivity disorder treated with guanfacine extended-release in routine Canadian clinical practice.
Child Adolesc Psychiatry Ment Health
; 15(1): 55, 2021 Oct 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34607580
5.
A Controlled Trial of Extended-Release Guanfacine and Psychostimulants on Executive Function and ADHD.
J Atten Disord
; 24(2): 318-325, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29313415
6.
Treatment Patterns, Health Care Resource Utilization, and Health Care Cost Associated with Atypical Antipsychotics or Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Quebec, Canada.
J Child Adolesc Psychopharmacol
; 29(10): 730-739, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31433205
7.
The impact of electronic consultation on a Canadian tertiary care pediatric specialty referral system: A prospective single-center observational study.
PLoS One
; 13(1): e0190247, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29320539
8.
Differences in Adverse Event Reporting Rates of Therapeutic Failure Between Two Once-daily Extended-release Methylphenidate Medications in Canada: Analysis of Spontaneous Adverse Event Reporting Databases.
Clin Ther
; 39(10): 2006-2023, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28988700
9.
Emotional dysregulation in children with attention-deficit/hyperactivity disorder.
Atten Defic Hyperact Disord
; 8(4): 175-187, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27299358
10.
Medication Persistence, Duration of Treatment, and Treatment-switching Patterns Among Canadian Patients Taking Once-daily Extended-release Methylphenidate Medications for Attention-Deficit/Hyperactivity Disorder: A Population-based Retrospective Cohort Study.
Clin Ther
; 38(8): 1789-802, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27478110
11.
Combination and switching of stimulants in children and adolescents with attention deficit/hyperactivity disorder in quebec.
J Can Acad Child Adolesc Psychiatry
; 23(3): 157-66, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25320609
12.
Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec.
Can J Psychiatry
; 59(11): 597-608, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25565476
13.
Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial.
Eur Neuropsychopharmacol
; 24(12): 1861-72, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25453486
14.
Predicting response of ADHD symptoms to methylphenidate treatment based on comorbid anxiety.
J Atten Disord
; 13(4): 414-9, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19401504
Resultados
1 -
14
de 14
1
Próxima >
>>